ASH 2023: MRD Highlights in BioPharma Drug Development

Read More

PD-1 blockade modulates chimeric antigen receptor (CAR)–modified T cells: refueling the CAR

Chong et al.
Blood
Papers
February 2017
Authors and Affiliates
Elise A. Chong,1 J. Joseph Melenhorst,2 Simon F. Lacey,2 David E. Ambrose,2 Vanessa Gonzalez,2 Bruce L. Levine,2 Carl H. June,2 and Stephen J. Schuster1 1Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; and 2Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA